Solid Biosciences (SLDB) Payables (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Payables for 8 consecutive years, with $3.5 million as the latest value for Q3 2024.
- Quarterly Payables rose 82.19% to $3.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Sep 2024, up 82.19% year-over-year, with the annual reading at $2.0 million for FY2023, 37.25% down from the prior year.
- Payables hit $3.5 million in Q3 2024 for Solid Biosciences, up from $2.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $5.6 million in Q1 2023 to a low of $1.7 million in Q1 2024.
- Historically, Payables has averaged $3.5 million across 5 years, with a median of $3.2 million in 2022.
- Biggest YoY gain for Payables was 82.19% in 2024; the steepest drop was 69.08% in 2024.
- Year by year, Payables stood at $3.3 million in 2020, then skyrocketed by 36.32% to $4.5 million in 2021, then fell by 27.45% to $3.2 million in 2022, then tumbled by 37.25% to $2.0 million in 2023, then soared by 70.18% to $3.5 million in 2024.
- Business Quant data shows Payables for SLDB at $3.5 million in Q3 2024, $2.5 million in Q2 2024, and $1.7 million in Q1 2024.